FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/06/043540 [Registered on: 28/06/2022] Trial Registered Prospectively
Last Modified On: 13/06/2022
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Other 
Public Title of Study   Role of cervical cancer microbiome during cervical cancer progression 
Scientific Title of Study   Influence of microbiome and mechanism during cervical cancer progression 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr K Satyamoorthy  
Designation  Professor and Director  
Affiliation  Manipal School of Life Sciences 
Address  Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal

Udupi
KARNATAKA
576104
India 
Phone  9845718604  
Fax    
Email  ksatyamoorthy@manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr K Satyamoorthy  
Designation  Professor and Director  
Affiliation  Manipal School of Life Sciences 
Address  Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal


KARNATAKA
576104
India 
Phone  9845718604  
Fax    
Email  ksatyamoorthy@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr K Satyamoorthy  
Designation  Professor and Director  
Affiliation  Manipal School of Life Sciences 
Address  Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal


KARNATAKA
576104
India 
Phone  9845718604  
Fax    
Email  ksatyamoorthy@manipal.edu  
 
Source of Monetary or Material Support  
Manipal Academy of Higher Education, Manipal 576104  
 
Primary Sponsor  
Name  Science for Equity Empowerment and Development  
Address  Department of Science & Technology, Government of India  
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr K Satyamoorthy  Kasturba Hospital  Department of Obstetrics & Gynaecology, Manipal, Karnataka, room number 13.
Udupi
KARNATAKA 
9845718604

ksatyamoorthy@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospotal Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C539||Malignant neoplasm of cervix uteri, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  No treatment  Not applicable 
Intervention  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  1. Women within the age group of 21-65 years with or without pre-malignant
2. malignant cervical lesions will be included in the study 
 
ExclusionCriteria 
Details  1. Women who are pregnant and /or lactating at the time of the study, women who have undergone hysterectomy adenocarcinoma of the cervix
2. Women who have been diagnosed and have already started treatment for cervical lesions and malignancies will be excluded 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The present study aims at the identification, characterization, and elucidation of relevant pathways and targets responsible for tumor progression cervical cancer upon HPV infection in relation to the co-inhabiting microbiome.   4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Not applicable   Not applicable  
 
Target Sample Size   Total Sample Size="260"
Sample Size from India="260" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/07/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The main objective of the study is to identify bacterial biomarkers, elucidate pathways that are responsible for tumor progression, and target the identified biological markers (pathways/proteins) by treating with specific sets of chemotherapeutic agents.  
Close